Medline (MDLN) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Medline

NasdaqGS•Healthcare•Medical Instruments & Supplies

$36.590.00(0.00%)Market closed

Market Cap

$27.52B

P/B

2.4x

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/B · 2.4x5y range 2.4x – 3.2x

Price & Volume

Market Cap $27.52B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $0
Q. Revenue: $7.68B
TTM EBITDA: $0
TTM Op. Income: $0
Q. Op. Income: $395.00M
TTM Net Income: $0
Q. Net Income: $139.00M
EPS: $0.07
Shares Out.: $856.67M

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 28.8%
EBITDA Margin: 8.5%
Op. Margin: 5.1%
Net Margin: 1.8%

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: N/A
P/B Ratio: 2.4x

P/S of 0.0x and P/B of 2.4x.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $39.35B
Cash: $2.33B
Long-Term Debt: $12.55B
Book Value: $11.57B
D/E Ratio: 1.1
Debt/EBITDA: 19.3

With $39.35B in assets and $12.55B in long-term debt, D/E is 1.1and book value is $11.57B — moderate leverage. Across the last 3 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.